Allison M. Deal

Jan 6, 2025 | onlinelibrary.wiley.com | Zev M. Nakamura |Allison M. Deal |Justin M. Yopp |Alexis C. Wardell

Data Availability Statement The protocol is available at clinicaltrials.gov. Data that support the findings of this study are available from the corresponding author upon reasonable request.

Apr 4, 2024 | onlinelibrary.wiley.com | Sarah J. Nyante |Allison M. Deal |Hillary M. Heiling |Kyung Su Kim

1 INTRODUCTION The COVID-19 pandemic disrupted cancer care, with US institutions reporting 80%–99% reductions in mammography and 45%–86% reductions in colon cancer screenings at the height of pandemic restrictions.1-11 Prior to the pandemic, a majority of eligible women participated in recommended cancer screening.

Sep 14, 2023 | brnw.ch | Victoria Blinder |Allison M. Deal |Brenda Ginos |Jennifer Jansen

CONTEXTKey ObjectiveDoes screening for financial toxicity (FT) prevent the development of financial difficulties in patients undergoing systemic therapy for advanced cancer?

Jul 4, 2023 | acsjournals.onlinelibrary.wiley.com | Shetal A. Patel |Michael Gibson |Allison M. Deal |Siddharth Sheth

Abstract Background Patients with locally advanced head and neck squamous cell cancer (HNSCC) are treated with surgery followed by adjuvant (chemo) radiotherapy or definitive chemoradiation, but recurrence rates are high. Immune checkpoint blockade improves survival in patients with recurrent/metastatic HNSCC; however, the role of chemo-immunotherapy in the curative setting is not established.

Jun 14, 2023 | onlinelibrary.wiley.com | Carmina G. Valle |Molly A. Diamond |Hillary M. Heiling |Allison M. Deal

4 DISCUSSION While PA is well-recognized as beneficial for cancer survivors, little research has examined longer-term PA change and maintenance among YACS. The IMPACT intervention offered a mobile PA intervention to YACS who are at risk for adverse effects from cancer decades following their treatment.